Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.85
Apr. 17, 2025 16:00:00- Change 0.045 (2.49307%)
- Volume 79,300
- Today's Open 1.8
- Previous Close 1.805
- Today's High 1.88
- Today's Low 1.8
- 52 Week High 4.3
- 52 Week Low 1.44